Found 14 matching trials
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse PHASE3 Prospective, multi-center, randomized, open label comparative Phase III stu...
Show More Location
University Clinic Ulm
Learn More & Join Trial
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients PHASE1 To determine the safety of administering anakinra plus the physician's chem...
Show More Location
Baylor University Medical Center
Learn More & Join Trial
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy PHASE3 A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC PHASE2 The purpose of this study is to evaluate the efficacy and safety of AAA617 ...
Show More Status
Active Not Recruiting
Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML PHASE3 The orally administered second-generation bis-aryl urea tyrosine kinase inh...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases PHASE3 The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy ...
Show More Learn More & Join Trial
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer PHASE3 This study is designed to compare the efficacy and safety of I-DXd with tre...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma. PHASE2 This is a multicenter phase 2/3 clinical study to evaluate the efficacy and...
Show More Location
Multiple Locations
Learn More & Join Trial
RGL-270 + ICI in Advanced NSCLC NA This is a single-center, open-label, investigator-initiated clinical trial....
Show More Location
Guangdong Provincial Perople's Hospital
Learn More & Join Trial
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers PHASE2 This study is being conducted to evaluate the safety and effectiveness of u...
Show More Location
Colorado Eye Consultants
Learn More & Join Trial